A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial.
Oncology
Seattle-based Fred Hutch Cancer Center and NASA have partnered on a pediatric cancer program that aims to alleviate patient fears about radiation therapy.
Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center had the lowest rate of methicillin-resistant Staphylococcus aureus infections for hospitals exempt from reporting to Medicare's Inpatient Prospective Payment System.
By 2050, the number of worldwide cancer cases and deaths will rise to 35.3 million and 18.5 million, respectively, according to a Nov. 5 study published in JAMA Open Network.
CMS released its 2025 Physician Fee Schedule Nov. 1, finalizing a conversion factor of $32.35, down 2.83% from $33.29 in 2024.
A team from Morgantown, W.Va.-based WVU Cancer Institute has become the first in the world to commercially use a new, FDA-approved medical device designed to lower the risk of esophageal cancer.
Houston-based University of Texas MD Anderson Cancer Center has appointed Jennifer Bickel, MD, as the center's first vice president and chief wellness officer.
Newport Beach, Calif.-based Hoag has launched an oncoplastic breast surgery fellowship, the first fellowship of its kind in the U.S.
In September 2023, Boston-based Dana-Farber Cancer Institute rolled out plans to build a freestanding cancer center with Boston-based Beth Israel Deaconess Medical Center, a move that will end the institute's existing oncology partnership with Brigham and Women's Hospital, also in…
As part of its Cancer Moonshot initiative, the Biden administration will launch a private sector pilot program by the end of the year to address pediatric cancer drug shortages.
